Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @MatzkinHealth
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MatzkinHealth
-
Prikvačeni tweet
I'm excited to share some insights on adoption strategy for digital health from our recent panel featuring executives from
@iRhythmTech@virtahealth@lumobodytech and@HealthAdvances. Special thanks to iRhythm for hosting and to the 75+ who attended.https://healthadvancesblog.com/2018/05/11/scaling-the-mountain-adoption-strategy-for-digital-health/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
I enjoyed reading this article about companies that are moving into the space of A blood test to screen for cancer They have an uphill battle that I fear they do not yet fully recognize [Thread]https://www.cnbc.com/2020/02/01/detecting-cancer-through-liquid-biopsies-freenome-grail-thrive.html …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wow that's a lot of $$$! Patient-centric digitally-enabled pharmacy models are sorely needed, especially in specialty pharmacy. Exciting development for a promising company. (Congrats,
@etxeba!)https://twitter.com/chrissyfarr/status/1222939305925963778 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This pivot highlights continued HCP resistance to clinical decision support (CDS). Even if admins decide they need it for quality and/or $$ reasons, front-line docs don't want to use it. So, instead, Syapse pivots to selling data services to drug co's, like Flatiron, Tempus, Cotahttps://twitter.com/RebeccaDRobbins/status/1222675428982177793 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
Must-read, describing experiences of
@SecAzar as he tries to get own hlth records (unsuccessfully), & has his meds misrecorded- i.e. the usual. He also lambasts anti-interop of certain EHR co's. https://buff.ly/38NIAyp Resonates w/recent@zakkohane@mandl https://buff.ly/2voLRFX pic.twitter.com/cz6vbWOu5D
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
Leadership News: Seasoned life sciences executive, Holger Müller, joins
@HealthAdvances as a Vice President! Holger will add to HA’s expanding#biopharma practice w/ a principal focus on European clients & those interested in European markets – learn more: http://bit.ly/HAleadershipnews-2020 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
Do you think "Hey, Epic!" is the first step from a big EHR (with
@NuanceHealth and @mmodal) enabling true competition for scribes, in a way that@SaykaraHealth and@SukiHQ have been doing already? Or just a basic voice gimmick?@amazon@googlehttps://www.healthcareitnews.com/news/epic-debut-ambient-voice-technology-assistant-himss20 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Poll time: 1 - EHRs are locked down. Hard for patients to access and for HCPs to share. Tech co's have no access. Privacy is 100%. 2- Health data flows freely. Easy ptnt access and HCP sharing. Tech co's get lots of data, some of it identifiable. Sometimes data becomes public.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Verily confirms that the Verily / iRhythm AF collaboration will be based on using Study Watch + Zio for continuous monitoring to enable screening, Dx, and patient monitoring in AF. Imagine this eventually becoming part of an
@Onduo-like model for CV disease... cc@dave_muoio https://twitter.com/iRhythmTech/status/1220759081348214784 …Tweet je nedostupan.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I can't get over the EPIC/Faulkner letter. Just outrageous to use fake concern for patients as a fig leaf for a position that is so obviously about self-interest. Reminds me of state medical boards fighting telemedicine. At least be better at faking that you care about patients.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
SCOOP: Verily Study Watch picks up new 510(k) for irregular pulse monitoring https://shar.es/a3Eoyh
@MobiHealthNews. Well done@dave_muoio.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
This is a great article about how difficult it is to run trials/assess digital therapeutics companies, esp when it comes to trial design Key difficulty is designing a sham arm similar enough to be compared, but not enough to trigger the same effect https://www.statnews.com/2020/01/21/will-the-fda-give-the-go-ahead-to-a-prescription-video-game-the-wait-goes-on-as-new-data-come-in/ …pic.twitter.com/24DdJBDsPr
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Can't say I ever expected to be quoted in FT talking about sensor-enabled toilet seats, but here we are. This article is a comprehensive and thoughtful look at Alphabet's future in healthcare, including both Google Health and Verily.https://twitter.com/hannahkuchler/status/1219316074878885888 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
There might be some icy stares across the corridor at HIMSS this year...https://www.cnbc.com/2020/01/17/epic-systems-warns-customers-it-will-stop-supporting-google-cloud.html?__source=twitter%7Cmain …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Paging
@SavageLucia for perspective on what this could mean for federal policy and for DTx overall...Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big news for digital therapeutics (DTx)? Buried inside ONC's new Federal HIT Strategic Plan: "Advance use of evidence-based DTx as treatment options... to prevent, manage, and treat conditions through smartphones, tablets, and other personal devices." https://www.healthit.gov/sites/default/files/page/2020-01/2020-2025FederalHealthIT%20StrategicPlan_0.pdf …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
My colleague Anastasios Pappas writes about the evolving clinical and economic evidence requirements for digital health technology in the UK.https://lnkd.in/gZF5hGc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
News: I talked to the CEO of struggling Proteus Digital Health to get an update on the situation there: — a codev deal with Otsuka is ending — unspecified number of layoffs — pivot to cancer/infectious diseases, away from mental illness/cardiohttps://www.statnews.com/2020/01/14/proteus-otsuka-key-pharma-partnership-unravels/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
Nice interview with colleagues Sheela Hegde and Leslie DeVoshttps://lnkd.in/g6G5W-3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
Pear Theraputics Expands Pipeline with
#MachineLearning,#DigitalTherapeutic and#DigitalBiomarker Technologies#digitalhealthhttps://www.biospace.com/article/releases/pear-therapeutics-expands-pipeline-with-machine-learning-digital-therapeutic-and-digital-biomarker-technologies/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew Matzkin proslijedio/la je Tweet
"Overcoming barriers to scale in digital therapeutics" A presentation i gave a few weeks ago at the Clinically Validated DTx Conference in Boston. Let me know what you agree or disagree with!https://www.slideshare.net/cwhogg/overcoming-barriers-to-scale-in-digital-therapeutics …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
affects engineering, product management, and ops